2019-2020
Continued to consolidate WEGO Intervention Business Group and its subsidiaries, acquired a controlling stake in NeuroVasc Technologies, Inc., and launched the XINSORB® Bioresorbable Sirolimus-eluting Scaffolds, Aortic Stent Grafts System, and Retriever for Mechanical Thrombectomy.
Released products:
Coronary Stent
Central Venous Catheter
Disposable Blood Pressure Transducer